Strategic, Transaction & Risk Advisory
Industry Overview
Investments, transactions, disputes, investigations, and major capital decisions involving radiopharmaceuticals, isotope production, accelerator technology, or regulated facilities require more than general technical review.
Decision-makers must understand whether an opportunity is technically credible, whether identified risks are manageable, whether projected capabilities are realistic, and whether an organization has the systems needed to execute successfully.
Isotope Strategies provides independent technical judgment for boards, executives, investors, developers, attorneys, insurers, and transaction teams confronting complex or high-consequence matters.
We translate specialized technical and regulatory issues into clear decision-relevant insight without oversimplifying the underlying risk.
Key Challenges and Priorities
Clients may need to evaluate questions such as:
Is the proposed technology or operating model technically viable?
Can the facility support the claimed products, throughput, or expansion plans?
Are regulatory assumptions realistic and adequately supported?
Do current radiation protection and EHS systems reflect the organization’s actual risk?
Are significant liabilities, constraints, or capital needs being underestimated?
Can identified issues be corrected within the proposed timeline and budget?
Is an incident or adverse outcome the result of an isolated failure or a broader systemic weakness?
Are competing technical opinions supported by the available evidence?
What risks should executives, investors, insurers, or legal teams understand before proceeding?
The challenge is often not a lack of information. It is determining which information matters, whether the assumptions are sound, and how technical findings affect the decision at hand.
How Isotope Strategies Supports Clients
Isotope Strategies provides focused independent support in areas including:
Technical due diligence for investments and acquisitions
Evaluation of facilities, operations, technology, and production capabilities
Review of radiation protection, regulatory, and EHS risk
Assessment of capital requirements and operational-readiness assumptions
Independent technical review for boards and executive teams
Pre-investment and pre-transaction risk assessment
Support for post-acquisition integration planning
Incident review and technical investigation
Litigation consulting and expert support
Review of technical claims, reports, and opposing opinions
Technical support for insurers and risk professionals
Independent advice during high-stakes or disputed decisions
Our work is tailored to the decision being made. We focus attention on material issues, explain the significance of technical findings, and distinguish between manageable concerns and risks that may fundamentally affect the opportunity or outcome.
We do not advocate for a predetermined conclusion. Our role is to provide objective, defensible analysis that enables the client to make an informed decision.
When to Engage Us
Clients may benefit from engaging Isotope Strategies:
Before acquiring or investing in a radiopharmaceutical or isotope-production business
During evaluation of a new facility, technology, or development opportunity
Before approving a major capital investment
When internal or external technical opinions conflict
When an executive team or board requires independent validation
Following an incident, regulatory issue, or unexpected operational event
During insurance, legal, or commercial disputes involving specialized technical matters
When assessing potential liabilities or remediation requirements
During post-transaction planning or integration
Whenever the consequences of an incorrect technical assumption are significant
Independent technical advice is most valuable when it is introduced early enough to influence the decision—not only after problems have emerged.
Submit an Inquiry
Provide project details to receive a tailored engagement outline.